Target intelligence / Profile preview

Reducing agent

Molecular classification
Other
01

Overview

A **reducing agent** is a substance that donates electrons to another chemical species during an oxidation-reduction (redox) reaction. In this process, the reducing agent itself becomes oxidized while causing the other reactant to be reduced. Reducing agents are essential for facilitating electron transfer in both laboratory and biological systems. Common examples include hydrogen gas, alkali metals, formic acid, carbon monoxide, and various hydride compounds. In biochemistry, molecules such as NADH serve as biological reducing agents critical for metabolic pathways. The term "reducing agent" refers broadly to any molecule or ion capable of acting as an electron donor; it does not refer to a single defined molecular entity but rather describes a functional role within redox chemistry. **Note:** "Reducing agent" is not considered a therapeutic target such as an enzyme or receptor; it is instead a general chemical concept describing function within redox reactions rather than identifying any specific protein or druggable biomolecule. Therefore, *is_target* should be marked false, and *is_incorrect* should be marked true, since this entry does not correspond to an individual molecular target suitable for structured pharmacological data extraction.

Other names
reductantreducerelectron donor
02

Mechanism of action

Electron donation to another species resulting in reduction of that species and oxidation of the reducing agent itself

03

Biological functions

Electron transferFacilitation of redox reactionsMetabolic processes (when referring to biological reducing agents like NADH)
04

Disease associations

Other (not a direct disease target; involved in general metabolic and chemical processes)
05

Safety considerations

Some strong reducing agents can react vigorously with water or oxygen and may be hazardous if not handled properly
06

Interacting drugs

null (Reducing agent is a functional class, not a specific molecular target for drugs. However, some drugs act as reducing agents or interact with them in chemical reactions.)

Beyond the preview

Go deeper on Reducing agent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reducing agent.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call